| Naiya Patel, | |
|
1830 E Laverne St, Bolivar, MO 65613-1488 | |
| (913) 744-8430 | |
| Not Available |
| Full Name | Naiya Patel |
|---|---|
| Gender | Female |
| Speciality | Licensed Practical Nurse |
| Location | 1830 E Laverne St, Bolivar, Missouri |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114610250 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164W00000X | Licensed Practical Nurse | 2023007974 (Missouri) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Naiya Patel, 1830 E Laverne St, Bolivar, MO 65613-1488 Ph: (913) 744-8430 | Naiya Patel, 1830 E Laverne St, Bolivar, MO 65613-1488 Ph: (913) 744-8430 |
News Archive
Anthera Pharmaceuticals, Inc., today announced that it has entered into definitive agreements with certain accredited investors in connection with a private placement, or PIPE, financing transaction pursuant to Section 4(2) of the Securities Act of 1933, as amended, and Regulation D promulgated thereunder.
The transcription factor Nanog plays a crucial role in the self-renewal of embryonic stem cells.
Health risks posed to people who work with tiny fibres used in manufacturing industries could be reduced, thanks to new research.
Detailed cholesterol testing for Type 2 diabetes patients is the focus of a newly published article by Atherotech Diagnostics Lab Chief Medical Officer Michael E. Cobble, M.D. The article discusses the clinical advantages of advanced cholesterol testing in reducing cardiovascular disease (CVD) risk in patients with Type 2 diabetes and details several currently available advanced lipid tests, including the VAP® Cholesterol Test from Atherotech.
Scientists at the Morgridge Institute for Research have discovered a promising new target to fight a class of viruses responsible for health threats such as Zika, polio, dengue, SARS and hepatitis C.
› Verified 1 days ago